FDA 510(k) clearance · back to tracker

CROATEST (R) RHEUMATOID DIAGNOSTIC

Biotrax, Inc. cleared K904416 on 1991-06-24, decision: substantially equivalent

K-number

K904416

Sponsor

Biotrax, Inc.

Device

CROATEST (R) RHEUMATOID DIAGNOSTIC

Class

Class I

Decision

Substantially Equivalent

Decision date

1991-06-24

Product code

GTQ

Advisory committee

Microbiology

Medical specialty

Microbiology

Regulation number

866.3720

Official FDA record

Open K904416on accessdata.fda.gov →

FDA's authoritative 510(k) summary page. Includes the decision letter, predicate references, and downloadable substantial-equivalence determination.

openFDA JSON

Raw record →

Machine-readable JSON. Useful for cross-referencing classification, product code, and advisory committee fields.

Use this as a predicate

Drop K904416 into Compass and start a substantial-equivalence draft.

Compass pulls the predicate's intended use, technological characteristics, and performance data, maps them against your device, and produces a draft SE table aligned to FDA's 510(k) program guidance.

Try the sandbox

Source

Public 510(k) database, U.S. Food and Drug Administration, accessed via openFDA. Page refreshed weekly.